Human Leukocyte Antigen

• Human Leukocyte Antigens (HLA) are cell surface proteins vital for immune system function, enabling the body to recognize and differentiate between its own cells and foreign invaders.
• The HLA system is crucial for initiating immune responses by presenting antigens to T-cells, thereby coordinating the body’s defense against pathogens and abnormal cells.
• HLA molecules are highly diverse, with specific types influencing susceptibility or resistance to various autoimmune diseases, infectious diseases, and even cancer.
• Understanding HLA types is fundamental in organ transplantation to minimize rejection, as well as in diagnosing and managing certain immune-mediated conditions.

What is Human Leukocyte Antigen (HLA)?

The Human Leukocyte Antigen (HLA) system refers to a group of genes on chromosome 6 that encode cell surface proteins crucial for the immune system. These proteins, also known as major histocompatibility complex (MHC) molecules in humans, are found on the surface of most cells in the body, particularly white blood cells (leukocytes). Their primary function is to present fragments of proteins, called antigens, to T-lymphocytes, which are key immune cells responsible for identifying and eliminating foreign invaders or abnormal cells.

The diversity within the HLA system is immense, making each individual’s HLA profile unique, much like a genetic fingerprint. This genetic variability is vital for the survival of the species, as it ensures that a population can collectively respond to a wide array of pathogens. The unique combination of HLA genes an individual inherits determines their specific immune recognition capabilities.

Role of HLA in Immune Response and Function

The role of HLA in immune response is fundamental to how the body defends itself against infections and diseases. HLA molecules act as “display cases” on cell surfaces, showcasing peptides derived from proteins. These peptides can be either “self” (from the body’s own proteins) or “non-self” (from pathogens like viruses or bacteria, or from cancerous cells). T-cells constantly survey these HLA-peptide complexes. If a T-cell recognizes a non-self peptide presented by an HLA molecule, it triggers an immune response to eliminate the threat.

The HLA system function explained involves two main classes of molecules, each with distinct roles:

• Class I HLA Molecules (HLA-A, HLA-B, HLA-C): These are found on nearly all nucleated cells. They primarily present peptides derived from proteins synthesized within the cell (endogenous antigens), such as viral proteins or abnormal proteins from cancerous cells. When a Class I HLA molecule presents a foreign peptide, it signals cytotoxic T-lymphocytes (CD8+ T-cells) to destroy the infected or abnormal cell.
• Class II HLA Molecules (HLA-DP, HLA-DQ, HLA-DR): These are mainly found on specialized antigen-presenting cells (APCs) like macrophages, dendritic cells, and B-cells. They present peptides derived from proteins acquired from outside the cell (exogenous antigens), such as bacteria or toxins that have been engulfed. When a Class II HLA molecule presents a foreign peptide, it activates helper T-lymphocytes (CD4+ T-cells), which then coordinate other immune cells to mount an appropriate response.

HLA Types and Associated Diseases

The extensive polymorphism of HLA genes leads to thousands of different HLA types and associated diseases. Certain HLA alleles are known to increase or decrease an individual’s susceptibility to various conditions, including autoimmune diseases, infectious diseases, and even some cancers. This association occurs because specific HLA types may be more or less efficient at presenting certain antigens, or they might present self-antigens in a way that triggers an autoimmune reaction.

For instance, HLA-B27 is strongly associated with ankylosing spondylitis, a chronic inflammatory disease primarily affecting the spine. Studies indicate that approximately 90-95% of individuals with ankylosing spondylitis carry the HLA-B27 allele, compared to 5-10% in the general population (Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH). Similarly, HLA-DR4 and HLA-DR1 are linked to an increased risk of rheumatoid arthritis. Understanding these associations is crucial for disease diagnosis, prognosis, and the development of targeted therapies.

In organ transplantation, matching HLA types between donor and recipient is paramount to prevent immune rejection. A close HLA match significantly reduces the likelihood that the recipient’s immune system will recognize the transplanted organ as foreign and attack it. This highlights the profound impact of HLA diversity on both health and medical interventions.